RS50023B - Farmaceutski sastav koji sadrži inhibitore protonske pumpe - Google Patents

Farmaceutski sastav koji sadrži inhibitore protonske pumpe

Info

Publication number
RS50023B
RS50023B YUP-504/01A YUP50401A RS50023B RS 50023 B RS50023 B RS 50023B YU P50401 A YUP50401 A YU P50401A RS 50023 B RS50023 B RS 50023B
Authority
RS
Serbia
Prior art keywords
pharmaceutical composition
composition containing
proton pump
pump inhibitors
containing proton
Prior art date
Application number
YUP-504/01A
Other languages
English (en)
Inventor
Keith Freehauf
Original Assignee
Merck & Co. Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc., filed Critical Merck & Co. Inc.,
Publication of YU50401A publication Critical patent/YU50401A/sh
Publication of RS50023B publication Critical patent/RS50023B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Farmaceutska formulacija za oralnu primenu, naznačena time, što uključuje. (a) 1% do 60% m/m omeprazola, (b) 0.1 % do 2% m/m od dva do četiri sredstva za bazifikaciju, (c) 1 % do 3% m/m sredstva za zgušnjavanje, i (d) hidrofobni uljasti tečni nosač koji uključuje (i) biljno ulje i (ii) trigliceride masnih kiselina sa srednjom dužinom lanca sa od 8-12 ugljenikovih atoma ili propilen-glikolne diestre masnih kiselina sa srednjom dužinom lanca - od 8-12 ug1jenikovih atoma. Prijava ima još 10 zahteva.
YUP-504/01A 1999-02-23 2000-02-18 Farmaceutski sastav koji sadrži inhibitore protonske pumpe RS50023B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12125399P 1999-02-23 1999-02-23

Publications (2)

Publication Number Publication Date
YU50401A YU50401A (sh) 2004-05-12
RS50023B true RS50023B (sr) 2008-09-29

Family

ID=22395498

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-504/01A RS50023B (sr) 1999-02-23 2000-02-18 Farmaceutski sastav koji sadrži inhibitore protonske pumpe

Country Status (31)

Country Link
US (1) US6316481B1 (sr)
EP (1) EP1156806B1 (sr)
JP (1) JP2002537337A (sr)
KR (1) KR100701448B1 (sr)
CN (1) CN1227009C (sr)
AR (1) AR029615A1 (sr)
AT (1) ATE263562T1 (sr)
AU (1) AU771061B2 (sr)
BG (1) BG65291B1 (sr)
BR (1) BR0008403A (sr)
CA (1) CA2362932C (sr)
CO (1) CO5140102A1 (sr)
CZ (1) CZ301647B6 (sr)
DE (1) DE60009675T2 (sr)
DK (1) DK1156806T3 (sr)
EA (1) EA004683B1 (sr)
ES (1) ES2216870T3 (sr)
HK (1) HK1041650A1 (sr)
HR (1) HRP20010615B1 (sr)
HU (1) HU228181B1 (sr)
IL (1) IL144131A0 (sr)
ME (1) ME00864B (sr)
NO (1) NO328863B1 (sr)
NZ (1) NZ512771A (sr)
PL (1) PL195783B1 (sr)
PT (1) PT1156806E (sr)
RS (1) RS50023B (sr)
SK (1) SK286371B6 (sr)
TW (1) TW587936B (sr)
WO (1) WO2000050038A1 (sr)
ZA (1) ZA200106104B (sr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
NZ522450A (en) 2000-05-30 2004-07-30 Merial Ltd Methods for prevention of ulcers
BR0115989A (pt) 2000-12-07 2004-01-13 Altana Pharma Ag Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
CA2430816C (en) 2000-12-07 2012-05-15 Altana Pharma Ag Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
JP4634144B2 (ja) 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
GB2394895A (en) * 2002-11-06 2004-05-12 Cipla Ltd Proton pump inhibitor composition in paste form
WO2005000269A1 (en) * 2003-06-26 2005-01-06 Cipla Limited Pharmaceutical formulations comprising a proton pump inhibitor
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
CN101500553B (zh) * 2006-07-25 2012-04-18 维克塔有限公司 联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法
US8309138B2 (en) 2007-02-16 2012-11-13 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
IN2012DN00359A (sr) 2009-07-20 2015-05-22 Vetegen Llc
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
WO2013165468A1 (en) * 2012-05-02 2013-11-07 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
GB2524351B (en) * 2013-10-18 2016-12-14 Norbrook Lab Ltd Proton Pump Inhibitor Paste Compositions
EP3057571B1 (en) * 2013-10-18 2019-03-06 Norbrook Laboratories Limited Proton pump inhibitor paste compositions
FI3386507T3 (fi) 2015-12-08 2023-09-06 Luoda Pharma Ltd Menetelmiä ja koostumuksia mahahaavojen hoitoon
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
ES2723873B1 (es) * 2018-03-01 2020-05-13 Hernan Ma Carmen Batanero Medicamento combinado con omeprazol y vitamina B12
CN112972481A (zh) * 2021-03-18 2021-06-18 华农（肇庆）生物产业技术研究院有限公司 药物组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255432A (en) 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
DK130287D0 (da) 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors

Also Published As

Publication number Publication date
EP1156806B1 (en) 2004-04-07
EA004683B1 (ru) 2004-06-24
SK12062001A3 (sk) 2001-12-03
DE60009675T2 (de) 2005-03-24
DK1156806T3 (da) 2004-08-02
BR0008403A (pt) 2002-01-29
CN1341022A (zh) 2002-03-20
CN1227009C (zh) 2005-11-16
KR20010102297A (ko) 2001-11-15
NZ512771A (en) 2003-02-28
AU771061B2 (en) 2004-03-11
KR100701448B1 (ko) 2007-03-30
PL195783B1 (pl) 2007-10-31
ES2216870T3 (es) 2004-11-01
NO20014074L (no) 2001-08-22
EA200100905A1 (ru) 2002-02-28
CO5140102A1 (es) 2002-03-22
HK1041650A1 (en) 2002-07-19
IL144131A0 (en) 2002-05-23
HUP0200325A3 (en) 2003-05-28
ATE263562T1 (de) 2004-04-15
PT1156806E (pt) 2004-07-30
ME00864B (me) 2008-09-29
CZ301647B6 (cs) 2010-05-12
EP1156806A1 (en) 2001-11-28
JP2002537337A (ja) 2002-11-05
HRP20010615A2 (en) 2002-12-31
TW587936B (en) 2004-05-21
NO328863B1 (no) 2010-05-31
BG105754A (en) 2002-03-29
DE60009675D1 (de) 2004-05-13
NO20014074D0 (no) 2001-08-22
AU3368700A (en) 2000-09-14
HRP20010615B1 (en) 2011-03-31
CA2362932A1 (en) 2000-08-31
HU228181B1 (en) 2013-01-28
ZA200106104B (en) 2002-12-24
CA2362932C (en) 2010-11-30
CZ20013058A3 (cs) 2001-11-14
SK286371B6 (sk) 2008-08-05
HUP0200325A2 (en) 2002-06-29
WO2000050038A1 (en) 2000-08-31
US6316481B1 (en) 2001-11-13
AR029615A1 (es) 2003-07-10
YU50401A (sh) 2004-05-12
BG65291B1 (bg) 2007-12-28
PL350729A1 (en) 2003-01-27

Similar Documents

Publication Publication Date Title
RS50023B (sr) Farmaceutski sastav koji sadrži inhibitore protonske pumpe
TW200531696A (en) Pharmaceutical formulations of bisphosphonates
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
ATE427925T1 (de) Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
RS51764B (sr) Transdermalna farmaceutska kompozicija
ATE429210T1 (de) Orale flüssige zusammensetzungen
SE0000773D0 (sv) New formulation
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
YU49202A (sh) Benzazolski derivati i njihova upotreba kao modulatora jnk
MX9801727A (es) Composicion farmaceutica para administracion oral.
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
SE0000774D0 (sv) New formulation
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
RS49602B (sr) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
MA29481B1 (fr) Derives d'azolopyridine-2-one en tant qu'inhibiteurs de lipase et de phospholipase
ES2140512T3 (es) Composiciones farmaceuticas que contienen derivados de estaurosporina y un gliceridos polialquilenglicolico.
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE69815724D1 (de) Transparente körperpflegemittel